title: ABO incompatible kidney transplantation on triple therapy compared with quadruple therapy.
authors.affiliation: Department of Nephrology, Toho University, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Aikawa
authors.forename: T
authors.initials: T
authors.lastname: Ohara
authors.forename: A
authors.initials: A
authors.lastname: Hasegawa
authors.forename: M
authors.initials: M
authors.lastname: Yamashita
authors.forename: T
authors.initials: T
authors.lastname: Hadano
authors.forename: M
authors.initials: M
authors.lastname: Shindo
authors.forename: T
authors.initials: T
authors.lastname: Mizuiri
authors.forename: T
authors.initials: T
authors.lastname: Fushimi
authors.forename: K
authors.initials: K
authors.lastname: Sakai
authors.forename: N
authors.initials: N
authors.lastname: Hirayama
authors.forename: K
authors.initials: K
authors.lastname: Arai
authors.forename: E
authors.initials: E
authors.lastname: Tajima
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis
chemical_list: D000017:ABO Blood-Group System; D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; C037258:gusperimus; D008775:Methylprednisolone